Bioinformatics News and Research

RSS

Bioinformatics is the application of information techniques for the storage, retrieval, and analysis of large quantities of biological data.

Scientists identify more aggressive chemotherapy treatment for childhood brain cancer

Scientists led by Newcastle University have been able to identify the group of children needing more intensive, aggressive chemotherapy treatment for the most common form of brain cancer.

2 Nov 2018

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

The development of immunotherapy, which mobilizes the body's own immune system to destroy cancer cells, is one of the greatest advances in cancer treatment, but immunotherapy can cause harm to healthy tissue in some patients.

31 Oct 2018

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its research in AI for drug discovery at BioCentury China HealthCare Summit in Shanghai, 13-14 of November.

31 Oct 2018

FDA approves ultra-high-field 7T Terra MRI scanner for clinical use

The ultra-high-field 7T Terra magnetic resonance imaging scanner at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute of the Keck School of Medicine of USC has received FDA approval for clinical use, opening up new avenues of care for patients with Alzheimer's disease, multiple sclerosis and other diseases that affect the brain.

31 Oct 2018

Type of alleged crime can increase jurors' confidence in guilt, finds new study

The more severe a crime, the more evidence you should have to prove someone did it. But a new Duke study, appearing Oct. 29 in Nature Human Behavior, has shown that the type of alleged crime can increase jurors' confidence in guilt.

30 Oct 2018

Insilico to present latest research on biomarkers at Investing in the Age of Longevity Conference

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest advances in human aging biomarker development at the Investing in the Age of Longevity Conference in London, 1 of November.

30 Oct 2018

New method allows detection of direct biomolecule interactions

Proteins are the building blocks of the cell. They do most of the work and are essential for the structure, function and dynamic regulation of the cell and body's tissues and organs.

26 Oct 2018

Research uncovers how sleeping stem cells in the mammary gland are awakened at puberty

Walter and Eliza Hall Institute researchers have discovered how the growth of milk-producing mammary glands is triggered during puberty. Sleeping stem cells in the mammary gland are awoken by a protein dubbed FoxP1, according to the research that was published today in the journal Developmental Cell.

25 Oct 2018

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia and a diagnostic test to determine which AML patients would most likely benefit from this treatment.

22 Oct 2018

Texas A&M and UTA establish Texas Genomics Core Alliance

Texas A&M University and The University of Texas at Arlington have established The Texas Genomics Core Alliance to increase access to and decrease costs of cutting-edge, high-throughput genomics sequencing technologies.

22 Oct 2018

Insilico to present advances in artificial intelligence at the Healthcare Innovation Summit Africa 2018

Insilico Medicine, a Rockville-based leader in next-generation artificial intelligence for drug discovery, biomarker development, and aging research, is pleased to announce the talk of its Head of Africa Artificial Intelligence for Healthcare Initiative, Iraneus Ogu, who will present alongside other academic thought leaders and industry experts at the 4th Healthcare Innovation Summit Africa 2018, one of the largest healthcare events in Africa.

12 Oct 2018

Top journal publishes special issue on deep learning for drug discovery and biomarker development

While the many concepts in artificial intelligence date back to the 20th century, the revolution in deep learning started around 2014-2015 when AI systems started outperforming humans in many tasks ranging from video games and image recognition to autonomous driving.

11 Oct 2018

Researchers unravel fresh clues as to how kidney stones form

Kidney stones--solid, pebble-like grit that forms when too much of certain minerals like calcium are in the urine--can strike men, women, and increasingly, children, and the presence and pain of stones afflicts more than 12 percent of the world's population.

11 Oct 2018

Study finds typical mutations in offspring of radar soldiers

The offspring of radar soldiers exposed to high doses of radiation during their service experience more genetic alterations than families without radiation exposure.

5 Oct 2018

National Institutes of Health supports novel drug discovery research

Approximately $1.7 million in new funding from the National Institutes of Health will enable a multidisciplinary team of University of Illinois at Chicago researchers to build a reference library of bacteria to help scientists quickly identify bacterial strains and analyze their disease-fighting potential.

5 Oct 2018

Expert proposes new model to generate automated updates of genetic test results

Maybe the genetic test report your doctor ordered says your DNA contains many “variants of unknown significance.” Currently, up to 70 percent of such reports are negative or inconclusive.

4 Oct 2018

A Single Platform to Sequence All Monoclonal Antibody Proteins

Having a single platform to sequence all monoclonal antibody proteins provides researchers with key information for research, development and drug discovery

From Rapid Novor Inc 3 Oct 2018

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology, published online an analysis of patient samples from the Intergroupe Francophone du Myéloma 2009 trial.

1 Oct 2018

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.

28 Sep 2018

New combination therapy shows potential in treating incurable HPV-related cancers

A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to the human papilloma virus (HPV) in a phase II clinical trial led by investigators at The University of Texas MD Anderson Cancer Center and reported in JAMA Oncology.

28 Sep 2018

Bioinformatics News and Research

Further Reading

Scientists identify more aggressive chemotherapy treatment for childhood brain cancer

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

FDA approves ultra-high-field 7T Terra MRI scanner for clinical use

Type of alleged crime can increase jurors' confidence in guilt, finds new study

Insilico to present latest research on biomarkers at Investing in the Age of Longevity Conference

New method allows detection of direct biomolecule interactions

Research uncovers how sleeping stem cells in the mammary gland are awakened at puberty

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Texas A&M and UTA establish Texas Genomics Core Alliance

Insilico to present advances in artificial intelligence at the Healthcare Innovation Summit Africa 2018

Top journal publishes special issue on deep learning for drug discovery and biomarker development

Researchers unravel fresh clues as to how kidney stones form

Study finds typical mutations in offspring of radar soldiers

National Institutes of Health supports novel drug discovery research

Expert proposes new model to generate automated updates of genetic test results

A Single Platform to Sequence All Monoclonal Antibody Proteins

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

New combination therapy shows potential in treating incurable HPV-related cancers

eBook: A guide to RNA sequencing eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News